The international Huntington’s Disease Regulatory Science Consortium (HD-RSC) developed a biological definition of Huntington’s disease (HD) and a…
Articles by Marta Figueiredo, PhD
Spending more time on leisure activities — which contributes to a person’s cognitive reserve, or the ability to improvise —…
Throughout 2021, Huntington’s Disease News brought you daily coverage of the latest scientific findings, treatment developments, and clinical trials related to…
The U.S. Food and Drug Administration (FDA) has given fast track designation to Prilenia Therapeutics’ pridopidine as a potential…
The interaction between FAN1 and MLH1 — two DNA repair proteins known to be genetic modifiers of Huntington’s disease…
No significant safety concerns were identified in the first eight Huntington’s disease patients treated with uniQure’s potential gene therapy…
Progression in Huntington’s disease may be due more to a gradual loss of the system that maintains the health of brain…
Roche has discontinued dosing in the Phase 3Â GENERATION HD1Â trial of its investigational therapy tominersen in adults with…
Women with Huntington’s disease have worse motor, cognitive, and depressive symptoms than men with the condition, according to data…
People with rare disorders have a worse healthcare experience than those affected by chronic diseases, according to the results of…